07 Jan 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Sanofi appointed Dr Gary J Nabel as the chairman of the company's Strategic Development and Scientific Advisory Council. Dr Nabel, currently senior vice president, chief scientific officer and deputy to Dr Elias Zerhouni, president, Global R&D, will succeed Dr Richard Klausner.
Dr Richard Klausner, the former executive director for Global Health of the Bill and Melinda Gates Foundation, occupied this position since March 1, 2011, providing overall direction and scientific leadership together with some of the most talented scientists around the world across the continuum from Discovery to Development to Delivery.
As part of his key responsibilities as the CSO for global R&D, Dr Nabel will direct the activities of the council, including selection, appointment and evaluation of advisers. "I am delighted that Dr Gary Nabel will continue to make this council a vital part of our efforts to open Sanofi's research and development to outside perspectives," said Dr Elias Zerhouni, president, Global R&D, Sanofi. "I also wish to recognize and warmly thank Dr Richard Klausner who has been an outstanding adviser to the council. Under his leadership and invaluable experience, he has played a key role in setting out the role and composition of a group of experienced and internationally recognized advisers."
Created in November 2010, the council is a unique structure developed to enhance scientific discovery in a collaborative approach and to further develop a truly world-class research and development platform for future innovation for the benefit of patients around the world. The role of the council is to advise Sanofi on new and emerging areas of science and technology as well as deepen Sanofi's relationship with the external scientific world by creating a strong network of scientists and institutional partnerships.